Table 3.
Outcome | Model | β-Coefficient | 95% CI | P Value |
---|---|---|---|---|
Hip BMD, g/cm2 | 1 | 0.21 | 0.04, 0.38 | .02 |
2 | 0.03 | −0.16, 0.22 | .74 | |
Cortical area, mm2 | 1 | 0.26 | 0.12, 0.40 | <.01 |
2 | 0.17 | −0.01, 0.35 | .06 | |
Cortical BMD, mg/cm3 | 1 | −0.11 | −0.36, 0.14 | .38 |
2 | −0.10 | −0.42, 0.23 | .55 | |
ECPC, mm | 1 | −0.20 | −0.33, −0.07 | <.01 |
2 | −0.10 | −0.26, 0.07 | .24 | |
Total bone area, mm2 | 1 | 0.21 | 0.06, 0.36 | .01 |
2 | 0.22 | 0.03, 0.42 | .02 | |
Cortical to total bone area ratio, % | 1 | 0.09 | −0.15, 0.32 | .47 |
2 | −0.07 | −0.38, 0.23 | .63 | |
Tibial SSI, mm3 | 1 | 0.26 | 0.12, 0.39 | <.01 |
2 | 0.24 | 0.07, 0.42 | .01 |
All outcome and exposure variables were standardized. Standardized β-coefficients represent SD change in outcome per SD change in exposure (log 1-legged hopping force). Model 1 was adjusted for age, gender, and height. Model 2 was adjusted for age, gender, height, and weight. For hip BMD, n = 182; for all other other outcomes, n = 113.